Works matching DE "ADALIMUMAB"
Results: 2238
Add or switch to systemics and biologics where topical paediatric hidradenitis suppurativa therapy fails.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 6, p. 211, doi. 10.1007/s40267-024-01076-7
- By:
- Publication type:
- Article
Several approved biologic agents are now available to treat paediatric plaque psoriasis.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 2, p. 72, doi. 10.1007/s40267-022-00896-9
- By:
- Publication type:
- Article
Efficacy of combined liman peloid baths and heliotherapy in the treatment of psoriasis at Cervia spa, Emilia, Italy.
- Published in:
- International Journal of Biometeorology, 2020, v. 64, n. 7, p. 1145, doi. 10.1007/s00484-020-01888-y
- By:
- Publication type:
- Article
Outcomes of adalimumab therapy in refractory punctate inner choroidopathy and multifocal choroiditis.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 6, p. 2013, doi. 10.1007/s00417-021-05539-9
- By:
- Publication type:
- Article
Reply on Comments on the paper "Clinical characteristics and treatment of pars planitis: an adalimumab experience" by Ozdemir et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Comments on the paper "Clinical characteristics and treatment of pars planitis: an adalimumab experience" by Ozdemir et al.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 6, p. 2065, doi. 10.1007/s00417-021-05527-z
- By:
- Publication type:
- Article
Clinical characteristics and treatment of pars planitis: an adalimumab experience.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 2, p. 561, doi. 10.1007/s00417-021-05398-4
- By:
- Publication type:
- Article
Changes in choroidal imaging parameters following adalimumab therapy for refractory noninfectious uveitis.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 5, p. 1273, doi. 10.1007/s00417-020-05032-9
- By:
- Publication type:
- Article
High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 1089, doi. 10.1007/s00228-024-03676-8
- By:
- Publication type:
- Article
Efficacy and safety of adalimumab in pediatric patients with Crohn's disease: A systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 3, p. 395, doi. 10.1007/s00228-023-03613-1
- By:
- Publication type:
- Article
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 891, doi. 10.1007/s00228-022-03294-2
- By:
- Publication type:
- Article
Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 11, p. 1319, doi. 10.1007/s00228-016-2103-4
- By:
- Publication type:
- Article
A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS).
- Published in:
- 2016
- By:
- Publication type:
- Letter
Pharmacokinetics of adalimumab in Crohn's disease.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Efficacy and safety of adalimumab for the Crohn's disease: a systematic review and meta-analysis of published randomized placebo-controlled trials.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 8, p. 907, doi. 10.1007/s00228-014-1702-1
- By:
- Publication type:
- Article
Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy.
- Published in:
- Digestive Diseases, 2024, v. 42, n. 4, p. 325, doi. 10.1159/000535647
- By:
- Publication type:
- Article
Comparative Analysis of the 3-Year Persistence Rate with Second-Line Vedolizumab and Tumor Necrosis Factor-α Inhibitors in Patients with Inflammatory Bowel Disease Followed in Gastroenterology Practices in Germany.
- Published in:
- Digestive Diseases, 2020, v. 38, n. 6, p. 466, doi. 10.1159/000506121
- By:
- Publication type:
- Article
Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.
- Published in:
- Digestive Diseases, 2018, v. 37, n. 1, p. 11, doi. 10.1159/000493121
- By:
- Publication type:
- Article
Pregnancy Outcomes of Patients Exposed to Adalimumab in Japan.
- Published in:
- Digestive Diseases, 2019, v. 37, n. 2, p. 123, doi. 10.1159/000493462
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Digestive Diseases, 2018, v. 37, n. 1, p. N.PAG
- Publication type:
- Article
In Crohn Disease, Biologic Dose Escalation is Common During Maintenance Phase, Study Reveals.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Analysis of access to treatment of patients with psoriatic arthritis within nationally founded treatment program B.35 "Treatment of active Psoriatic arthritis (PsA) (ICD-10 L 40.5, M 07.1, M 07.2, M 07.3)" in 2016-2021.
- Published in:
- Forum Dermatologicum, 2023, v. 9, n. 1, p. 1, doi. 10.5603/FD.a2023.0001
- By:
- Publication type:
- Article
Analiza dostępu do leczenia pacjentów z łuszczycą w ramach programu lekowego B.47 „Leczenie umiarkowanej i ciężkiej postaci łuszczycy plackowatej (ICD-10 L 40.0)” w latach 2016–2021.
- Published in:
- Forum Dermatologicum, 2022, v. 8, n. 3, p. 111, doi. 10.5603/FD.a2022.0021
- By:
- Publication type:
- Article
Rheumatoid factor titers, but not Fc fragments, may be strongly associated with drug survival of anti-TNF agents in patients with rheumatoid arthritis.
- Published in:
- Northern Clinics of Istanbul, 2024, v. 11, n. 2, p. 147, doi. 10.14744/nci.2023.01643
- By:
- Publication type:
- Article
Adalimumab Treatment in a Case of Treatment-Resistant Acne Conglobata.
- Published in:
- European Journal of Therapeutics, 2024, v. 30, n. 4, p. 562, doi. 10.58600/eurjther2220
- By:
- Publication type:
- Article
Favorable efficacy of adalimumab treatment in experimental acute pancreatitis model.
- Published in:
- Turkish Journal of Medical Sciences, 2022, v. 52, n. 6, p. 1821, doi. 10.55730/1300-0144.5528
- By:
- Publication type:
- Article
Survival of biological therapeutics in psoriasis: retrospective analysis of 3-years data in a Turkish registry, PSORTAKSIS.
- Published in:
- Turkish Journal of Medical Sciences, 2022, v. 52, n. 1, p. 58, doi. 10.3906/sag-2104-339
- By:
- Publication type:
- Article
Antiinflammatory effects of adalimumab, tocilizumab, and steroid on lipopolysaccharide-induced lung injury.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 5, p. 2741, doi. 10.3906/sag-2010-303
- By:
- Publication type:
- Article
USPTO's Lax Policy Leads to Humira Formulation Thicket.
- Published in:
- Journal of Law, Medicine & Ethics, 2024, v. 52, n. 2, p. 429, doi. 10.1017/jme.2024.132
- By:
- Publication type:
- Article
Addressing High Drug Prices by Reforming Pharmacy Benefit Managers.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 46, doi. 10.1017/jme.2024.23
- By:
- Publication type:
- Article
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 646, doi. 10.3390/vaccines10050646
- By:
- Publication type:
- Article
Adalimumab in Treating Refractory Livedoid Vasculopathy.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040549
- By:
- Publication type:
- Article
Efficacy and prognosis of adalimumab for Crohn’s disease at different disease locations: a systematic review and meta-analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 6, p. 2036
- By:
- Publication type:
- Article
Relationship between injection site reactions and different adalimumab formulations. Analysis of the adverse events reported in Italy in 2016-2019.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 8, p. 3300
- By:
- Publication type:
- Article
Disease-Modifying Antirheumatic Drugs (DMARDs) and drug interactions in dentistry.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 7, p. 2834
- By:
- Publication type:
- Article
Differences in biologics for treating ankylosing spondylitis: the contribution of network meta-analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 1, p. 56
- By:
- Publication type:
- Article
Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component.
- Published in:
- Russian Journal of General Chemistry, 2014, v. 84, n. 2, p. 345, doi. 10.1134/S1070363214020364
- By:
- Publication type:
- Article
The CD147 expression in CD4<sup>+</sup> T cells is a novel biomarker for predicting efficacy of IL‐17A inhibitor and psoriasis recurrence.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 2, p. 1, doi. 10.1002/ctm2.1568
- By:
- Publication type:
- Article
Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas.
- Published in:
- Colorectal Disease, 2012, v. 14, n. 10, p. 1217, doi. 10.1111/j.1463-1318.2012.02944.x
- By:
- Publication type:
- Article
Anti tumour necrosis factor as risk factor for free perforations in Crohn's disease? A case-control study.
- Published in:
- Colorectal Disease, 2012, v. 14, n. 5, p. 578, doi. 10.1111/j.1463-1318.2011.02764.x
- By:
- Publication type:
- Article
Safety of antitumour necrosis factor treatments in chronic rheumatic diseases: therapy discontinuations related to side effects.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 3, p. 306, doi. 10.1111/jcpt.12393
- By:
- Publication type:
- Article
Iatrogenic Cushing's syndrome related to the interaction between oral budesonide with fluvoxamine: a case report.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 5, p. 612, doi. 10.1111/jcpt.12312
- By:
- Publication type:
- Article
On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 2, p. 131, doi. 10.1111/jcpt.12243
- By:
- Publication type:
- Article
Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 3, p. 307, doi. 10.1111/jcpt.12148
- By:
- Publication type:
- Article
Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2013, v. 38, n. 4, p. 286, doi. 10.1111/jcpt.12045
- By:
- Publication type:
- Article
Biological treatments for moderate-to-severe psoriasis: indirect comparison.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2013, v. 38, n. 2, p. 121, doi. 10.1111/jcpt.12044
- By:
- Publication type:
- Article
Indirect comparison of biological treatments in refractory rheumatoid arthritis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 3, p. 301, doi. 10.1111/j.1365-2710.2011.01292.x
- By:
- Publication type:
- Article
Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1180170
- By:
- Publication type:
- Article
HLAII peptide presentation of infliximab increases when complexed with TNF.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.932252
- By:
- Publication type:
- Article
Adalimumab in a patient with refractory idiopathic granulomatous mastitis: A case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study